Mekata, Hirohisa
Yamada, Kentaro
Umeki, Kazumi
Yamamoto, Mari
Ochi, Akihiro
Umekita, Kunihiko
Kobayashi, Ikuo
Hirai, Takuya
Okabayashi, Tamaki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0108495, JP21fk0108495, JP21fk0108495, JP21fk0108495)
Article History
Received: 27 October 2023
Accepted: 29 April 2024
First Online: 11 May 2024
Declarations
:
: All sampling procedures complied with international and Japanese regulations. The use of residual serum from Misaki horses and the collection of ticks in Cape Toi were approved by the Educational Committee of Kushima City, Miyazaki Prefecture, Japan (approval no. 520–573 on November 11, 2021; approval no. 520–644 on June 3, 2021). The preparation of mouse anti-SFTSV NP antibodies for use in the neutralization assays was approved by the Oita University Animal Experimentation Committee (approval no. P01001).
: Not applicable.
: The authors declare no competing interests.